Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zuqiang Liu, Roshni Ravindranathan, Jun Li, Pawel Kalinski, Z. Sheng Guo & David L. Bartlett. (2016) CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy. OncoImmunology 5:3.
Read now
Read now
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Read now
Nicolas Boisgerault, Carole Achard, Tiphaine Delaunay, Laurent Cellerin, Frédéric Tangy, Marc Grégoire & Jean-François Fonteneau. (2015) Oncolytic virotherapy for human malignant mesothelioma: recent advances. Oncolytic Virotherapy 4, pages 133-140.
Read now
Read now
Erika Vacchelli, Ilio Vitale, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fučíková, Isabelle Cremer, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:10.
Read now
Read now
Articles from other publishers (9)
Yaomei Tian, Daoyuan Xie & Li Yang. (2022) Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Jonathan G. Pol, Samuel T. Workenhe, Prathyusha Konda, Shashi Gujar & Guido Kroemer. (2020) Cytokines in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 4-27.
Crossref
Crossref
Tiphaine Delaunay, Carole Achard, Nicolas Boisgerault, Marion Grard, Tacien Petithomme, Camille Chatelain, Soizic Dutoit, Christophe Blanquart, Pierre-Joseph Royer, Stéphane Minvielle, Lisa Quetel, Clément Meiller, Didier Jean, Delphine Fradin, Jaafar Bennouna, Antoine Magnan, Laurent Cellerin, Frédéric Tangy, Marc Grégoire & Jean-François Fonteneau. (2020) Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Journal of Thoracic Oncology 15:5, pages 827-842.
Crossref
Crossref
Tiphaine Delaunay, Carole Achard, Marc Grégoire, Frédéric Tangy, Nicolas Boisgerault & Jean-François Fonteneau. 2020. Oncolytic Viruses. Oncolytic Viruses
127
132
.
Elena Tomasello, Karima Naciri, Rabie Chelbi, Gilles Bessou, Anissa Fries, Elise Gressier, Abdenour Abbas, Emeline Pollet, Philippe Pierre, Toby Lawrence, Thien‐Phong Vu Manh & Marc Dalod. (2018)
Molecular dissection of plasmacytoid dendritic cell activation
in vivo
during a viral infection
. The EMBO Journal 37:19.
Crossref
Crossref
Kwame Twumasi-Boateng, Jessica L. Pettigrew, Y. Y. Eunice Kwok, John C. Bell & Brad H. Nelson. (2018) Oncolytic viruses as engineering platforms for combination immunotherapy. Nature Reviews Cancer 18:7, pages 419-432.
Crossref
Crossref
Youra Kim, Derek Clements, Andra Sterea, Hyun Jang, Shashi Gujar & Patrick Lee. (2015) Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy. Viruses 7:12, pages 6506-6525.
Crossref
Crossref
Xiaoming Zhang, Nicoletta Casartelli, Sebastien Lemoine, Brian Mozeleski, Elie Azria, Camille Le Ray, Olivier Schwartz, Odile Launay, Claude Leclerc & Richard Lo-Man. (2014) Plasmacytoid Dendritic Cells Engagement by Influenza Vaccine as a Surrogate Strategy for Driving T-Helper Type 1 Responses in Human Neonatal Settings. The Journal of Infectious Diseases 210:3, pages 424-434.
Crossref
Crossref
Shashi A. Gujar & Patrick W. K. Lee. (2014) Oncolytic Virus-Mediated Reversal of Impaired Tumor Antigen Presentation. Frontiers in Oncology 4.
Crossref
Crossref